TERT and mature T-cell and NK-cell non-Hodgkin lymphoma: Since the TERT expression in PTCL is thought to be controlled by various mechanisms other than the promoter site mutations, we investigated the clinical impact of TERT protein expression in our PTCL cases (Figure 2).